These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15926128)

  • 21. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
    Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
    Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design.
    Hummel B; Walden J; Stampfer R; Dittmann S; Amann B; Sterr A; Schaefer M; Frye MA; Grunze H
    Bipolar Disord; 2002 Dec; 4(6):412-7. PubMed ID: 12519102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticonvulsant drugs in the treatment of substance withdrawal.
    Zullino DF; Khazaal Y; Hättenschwiler J; Borgeat F; Besson J
    Drugs Today (Barc); 2004 Jul; 40(7):603-19. PubMed ID: 15510234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multicenter observational study of the effect of oxcarbazepine on the general well-being of adults with partial epilepsy].
    Balogh A; Szentesi A; Jánosi I
    Ideggyogy Sz; 2010 Nov; 63(11-12):385-95. PubMed ID: 21413440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.
    Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Aug; 45(8):895-907. PubMed ID: 15270754
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal.
    Schik G; Wedegaertner FR; Liersch J; Hoy L; Emrich HM; Schneider U
    Addict Biol; 2005 Sep; 10(3):283-8. PubMed ID: 16109591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
    Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
    Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
    Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.
    Vendrame M; Khurana DS; Cruz M; Melvin J; Valencia I; Legido A; Kothare SV
    Epilepsia; 2007 Nov; 48(11):2116-20. PubMed ID: 17645535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial.
    Malcolm R; Myrick H; Roberts J; Wang W; Anton RF; Ballenger JC
    J Gen Intern Med; 2002 May; 17(5):349-55. PubMed ID: 12047731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retention rate of oxcarbazepine monotherapy in an unselected population of adult epileptics.
    Rainesalo S; Peltola J; Auvinen A; Keränen T
    Seizure; 2005 Jan; 14(1):72-4. PubMed ID: 15642505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal pattern of oxcarbazepine and phenytoin withdrawal seizures during epilepsy monitoring.
    Azar NJ; Wang L; Song Y; Abou-Khalil BW
    Epilepsy Res; 2008 Mar; 79(1):78-83. PubMed ID: 18281195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.
    Park KJ; Kim JR; Joo EY; Seo DW; Hong SB; Ko JW; Kim SR; Huh W; Lee SY
    Clin Neuropharmacol; 2012; 35(1):40-4. PubMed ID: 22246398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of oxcarbazepine for treatment of refractory status epilepticus.
    Kellinghaus C; Berning S; Stögbauer F
    Seizure; 2014 Feb; 23(2):151-4. PubMed ID: 24295895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
    Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
    Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine and oxcarbazepine in adult patients with Dravet syndrome: Friend or foe?
    Snoeijen-Schouwenaars FM; Veendrick MJ; van Mierlo P; van Erp G; de Louw AJ; Kleine BU; Schelhaas HJ; Tan IY
    Seizure; 2015 Jul; 29():114-8. PubMed ID: 26076853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benzodiazepines in the treatment of alcoholism].
    Ades J; Rodière C
    Encephale; 1983; 9(4 Suppl 2):293B-298B. PubMed ID: 6373235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.